1, such as inquiring about the basic information of drugs (drug product specification, dosage form, original research enterprise, registration category, indications, action mechanism, usage and dosage, adverse reactions), domestic registration declaration (enterprise declaration according to new registration classification/conformity evaluation, clinical trial registration, drug approval progress, clinical approval number, etc.). )
The above data can be found in the global drug research and development database, drug evaluation database, drug clinical database, etc., to help pharmaceutical companies provide decision analysis in project establishment.
Pharmaceutical institutions
2. It has been approved for listing at home and abroad (understand the approval of the same dosage form/different dosage forms, different specifications, the same dosage form and the same target, etc.). , API registration and filing information, the world's first approval information).
The above information can be found in the "Global Listed Drugs Database" to understand the information of listed drugs in various countries, mainly comparing the information of listed drugs in China, the United States, Japan and Europe, and providing data support for drug project research.
Pharmaceutical institutions
The API database contains API registration information, which can be used to query API data information.
Raw materials for drug project investigation
3. Investigate the market access information (medical insurance varieties, centralized procurement products, and whether the drugs have won the bid (highest, lowest, average)). These data are queried in the medical insurance catalogue database under rational drug use, and relevant drug data are obtained from the national drug centralized procurement and drug bidding data under market information, so as to analyze the drug market and investigate the market competitiveness of R&D varieties.
Bidding and centralized procurement in drug project establishment
Medical insurance catalogue
4. Analysis of domestic and international pharmaceutical market sales data (global or domestic drug sales analysis in recent five years), using drug sales data (hospitals, sample hospitals, pharmacies, global drug sales, etc. ) to query and analyze the drug sales data, including the sales data of a single variety, the sales data of active ingredients, the sales data of a certain drug field and the sales data of pharmaceutical companies. Using these sales data can help the project department of pharmaceutical companies screen and analyze drug varieties. The marketing department and the sales department can adjust the sales strategy in time through the sales data and create a higher sales quota, mainly by calculating the input-output ratio.
Drug sales situation
5. Clinical value (general situation of treatment field, clinical trial scheme, domestic and foreign guidelines recommendation) and competitive product comparison (clinical value/treatment status comparison, market performance comparison) can be analyzed through clinical trial database, clinical diagnosis and treatment guidelines database, etc. The analysis of competing products can also be realized through the data in the database.
6. Patent information (obstacle patent, patent expiration time, patent of the same family, etc.). ), use Rong Yun's global patent database and China's patent database to query patent information, understand the patent situation of drugs, avoid infringement, and also query related process parameters in patent information.
In addition to the above, we should also consider the R&D of our own enterprises, the matching of production and sales, and the analysis of R&D investment and production investment. The main purpose of drug research and development is to make money, and investment analysis and production analysis must be taken seriously.